These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 29490144

  • 1. Characterizing the Surface Roughness Length Scales of Lactose Carrier Particles in Dry Powder Inhalers.
    Tan BMJ, Chan LW, Heng PWS.
    Mol Pharm; 2018 Apr 02; 15(4):1635-1642. PubMed ID: 29490144
    [Abstract] [Full Text] [Related]

  • 2. Improving Dry Powder Inhaler Performance by Surface Roughening of Lactose Carrier Particles.
    Tan BM, Chan LW, Heng PW.
    Pharm Res; 2016 Aug 02; 33(8):1923-35. PubMed ID: 27091033
    [Abstract] [Full Text] [Related]

  • 3. Surface Modification of lactose carrier particles using a fluid bed coater to improve fine particle fraction for dry powder inhalers.
    Gong QQ, Tay JYS, Veronica N, Xu J, Heng PWS, Zhang YP, Liew CV.
    Pharm Dev Technol; 2023 Feb 02; 28(2):164-175. PubMed ID: 36683577
    [Abstract] [Full Text] [Related]

  • 4. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ, Jain RR, Soni PS, Abdul S, Darshana H, Gaikwad RV, Menon MD.
    J Aerosol Med Pulm Drug Deliv; 2015 Aug 02; 28(4):254-67. PubMed ID: 25517187
    [Abstract] [Full Text] [Related]

  • 5. An investigation into the effect of fine lactose particles on the fluidization behaviour and aerosolization performance of carrier-based dry powder inhaler formulations.
    Kinnunen H, Hebbink G, Peters H, Shur J, Price R.
    AAPS PharmSciTech; 2014 Aug 02; 15(4):898-909. PubMed ID: 24756910
    [Abstract] [Full Text] [Related]

  • 6. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW, Schneider M, Morrical BD, Imanidis G.
    J Pharm Sci; 2018 Apr 02; 107(4):984-998. PubMed ID: 29247741
    [Abstract] [Full Text] [Related]

  • 7. Synergistic effect of magnesium stearate and fine lactose in improving aerosolization performance of fluticasone propionate in dry powder formulation.
    He X, Li J, Wen X, Ma S, An Y, Zhang X, Guan J, Mao S.
    Int J Pharm; 2024 Oct 25; 664():124609. PubMed ID: 39163928
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations.
    Chan LW, Lim LT, Heng PW.
    J Pharm Sci; 2003 May 25; 92(5):975-84. PubMed ID: 12712417
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):81-9. PubMed ID: 16442246
    [Abstract] [Full Text] [Related]

  • 13. Effect of Roughness on the Dispersion of Dry Powders for Inhalation: a Dynamic Visualization Perspective.
    Kou X, Heng PWS, Chan LW, Wereley ST, Carvajal MT.
    AAPS PharmSciTech; 2019 Jul 30; 20(7):271. PubMed ID: 31363868
    [Abstract] [Full Text] [Related]

  • 14. Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations.
    Donovan MJ, Smyth HD.
    Int J Pharm; 2010 Dec 15; 402(1-2):1-9. PubMed ID: 20816928
    [Abstract] [Full Text] [Related]

  • 15. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
    Mönckedieck M, Kamplade J, Fakner P, Urbanetz NA, Walzel P, Steckel H, Scherließ R.
    Int J Pharm; 2017 May 30; 524(1-2):351-363. PubMed ID: 28347847
    [Abstract] [Full Text] [Related]

  • 16. Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.
    Sun Y, Qin L, Li J, Su J, Song R, Zhang X, Guan J, Mao S.
    AAPS J; 2021 Apr 15; 23(3):55. PubMed ID: 33856568
    [Abstract] [Full Text] [Related]

  • 17. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO, Molokhia AM, Elsayed MM.
    Eur J Pharm Biopharm; 2015 Oct 15; 96():291-303. PubMed ID: 26275831
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Defining the critical material attributes of lactose monohydrate in carrier based dry powder inhaler formulations using artificial neural networks.
    Kinnunen H, Hebbink G, Peters H, Shur J, Price R.
    AAPS PharmSciTech; 2014 Aug 15; 15(4):1009-20. PubMed ID: 24831088
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.
    Du P, Du J, Smyth HD.
    AAPS PharmSciTech; 2014 Dec 15; 15(6):1417-28. PubMed ID: 24962007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.